R Squared’s Idexx Laboratories IDXX Stock Holding History

R Squared’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-390	Closed	-$161K	–	849
2024 Q4	$161K	Buy	+390	New	+$171K	0.16%	154

Other funds holding IDXX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

R Squared's IDXX Position: Q1 2025 in Review

R Squared sold out of Idexx Laboratories (IDXX) in Q1 2025, closing a stake of 390 shares — an estimated $161K sold.

R Squared first reported a position in IDXX in Q4 2024 and held it in 1 quarter. The position peaked at $161K in Q4 2024. 1,142 funds tracked by Wall St. Rank hold IDXX as of Q1 2025.

R Squared reported no remaining Idexx Laboratories position as of Q1 2025 after selling out during the quarter.
R Squared sold 390 Idexx Laboratories shares in Q1 2025, an estimated $161K.
R Squared first reported a position in Idexx Laboratories in Q4 2024 and held it in 1 quarter.
R Squared's Idexx Laboratories position peaked at $161K in Q4 2024.
1,142 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2025.

Based on R Squared's 13F filing for Q1 2025, filed 9 May 2025.